Literature DB >> 20084910

[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].

Feza Bacakoğlu1, Pervin Korkmaz Ekren, Mehmet Sezai Taşbakan, Burcu Başarik, Hüsnü Pullukçu, Söhret Aydemir, Alev Gürgün, Ozen Kaçmaz Başoğlu.   

Abstract

Multidrug-resistant Acinetobacter boumannii is a challenge in the treatment and control of nosocomial infections. This retrospective study was aimed to investigate the prevalence of multidrug resistant A. boumannii in a respiratory intensive care unit (ICU), related risk factors and its impact on disease prognosis. Of 218 patients who were hospitalized in our ICU during the last two years; 37 (17%) patients (21 males, mean age 61.6 +/- 19.8 years) developed pneumonia and/or bacteremia due to multidrug-resistant A. baumannii. Previous antibiotic therapy was detected in 51.4% and hospitalization in 70.3% of the cases. Pneumonia (59.5%) was the most frequent cause of hospitalization and chronic obstructive pulmonary disease (21.6%) was the second one; 81.1% of patients had co-morbidity. Invasive mechanical ventilation was performed in 31 (83.7%) patients during the follow-up. Ventilator-associated pneumonia developed in 22 (59.5%) patients and bacteraemia in 9 (24.3%) patients. Multidrug-resistance was observed in 23 (62.2%) of patients. Highest rates of resistance (100%) was detected against piperacillin-tazobactam, ampicillin-sulbactam and ciprofloxacin, followed by imipenem and cefepime (78%), meropenem and ceftazidime (55%), cefoperazone-sulbactam (43%) and netilmicin (35.1). The rates of re-intubation and tracheotomy were higher in patients infected with A. boumannii compared to the control group (59.5% vs. 7.7%, p < 0.0001 and 21.6% vs. 3.9%, p = 0.001, respectively). There was no significant difference between two groups in terms of mortality, however, durations of ICU and hospital stays were longer in patients with multidrug-resistant A. baumannii infection than without infection (24.2 +/- 18.3 vs. 8.2 +/- 8.3 days, p < 0.001 and 33.3 +/- 19.8 vs. 15.4 +/- 11.4 days, p < 0.001, respectively). In conclusion, due to the high rates of drug-resistance in nosocomial A.baumannii isolates, the use of invasive procedures and durations of ICU and hospital stays exhibit an increasing trend.

Entities:  

Mesh:

Year:  2009        PMID: 20084910

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  3 in total

1.  Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis.

Authors:  Dong Xiao; Lu Wang; Daquan Zhang; Dongming Xiang; Qi Liu; Xuezhong Xing
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

2.  Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit.

Authors:  Manoj Kumar Sahu; Bharat Siddharth; Arin Choudhury; Sreenivas Vishnubhatla; Sarvesh Pal Singh; Ramesh Menon; Poonam Malhotra Kapoor; Sachin Talwar; Shiv Choudhary; Balram Airan
Journal:  Ann Card Anaesth       Date:  2016 Apr-Jun

3.  Nosocomial infections in surgical intensive care unit: A retrospective single-center study.

Authors:  Ajit Subhash Baviskar; Khalid Ismail Khatib; Deepali Rajpal; Harshad Chandrakant Dongare
Journal:  Int J Crit Illn Inj Sci       Date:  2019 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.